Optical coherence tomography versus angiography to guide percutaneous coronary intervention in patients with in-stent restenosis: an observational study.
Yi-Fei Wang, Tian Xu, Pei-Na Meng...
https://pubmed.ncbi.nlm.nih.gov/39620882/Actively Recruiting
Led by Nanjing First Hospital, Nanjing Medical University · Updated on 2025-12-22
1500
Participants Needed
1
Research Sites
39 weeks
Total Duration
This research aims to compare the clinical and angiographic results in patients with drug-eluting stent in-stent restenosis DES-ISR who undergo repeat percutaneous coronary intervention PCI using either intravascular imaging or angiographic guidance. DES-ISR is a condition where a previously placed drug-eluting stent narrows again, leading to complex mechanisms that can affect long-term heart health. Intravascular imaging techniques like OCT or IVUS provide detailed information about the artery and lesion, which may influence treatment choices and outcomes. Participants receive repeat PCI using one of two approaches intravascular imaging-guided PCI or angiography-guided PCI for lesions diagnosed with ISR. The study compares these two guidance methods to evaluate their efficacy and safety in treating DES-ISR. Treatment selection is based on detailed vessel and lesion characteristics obtained through these imaging methods. During the study, participants will be monitored for major adverse cardiac events MACE over three years, which is the primary outcome. Additional measurements taken during the procedure include stent expansion and minimal stent area MSA. The study involves follow-up to assess clinical outcomes and angiographic data quality, ensuring safety and effectiveness of the imaging guidance methods in PCI for DES-ISR patients.
CONDITIONS
Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR
F
Fei Ye, MD
Y
Yi-fei Wang, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nanjing First Hospital, Nanjing Medical University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single procedure with intraprocedural assessments
Participants undergo percutaneous coronary intervention (PCI) guided either by intravascular imaging or angiography to treat drug-eluting stent in-stent restenosis lesions.
1 procedure visit (in-person)
Duration - 3 years
Participants are monitored for major adverse cardiac events and stent performance over a period of 3 years following the intervention.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Yi-Fei Wang, Tian Xu, Pei-Na Meng...
https://pubmed.ncbi.nlm.nih.gov/39620882/Nanjing First Hospital, Nanjing Medical University
Lead Sponsor